FIELD: biotechnology. SUBSTANCE: human abortive serum is mixed with product obtained by mixing serum with antibodies raised to human alpha- fetoprotein with normal human serum in the ratio 10:1. Mixture is centrifuged, precipitate is dissolved in physiological solution, pH = 2, cooled ethyl alcohol is added to solution in the ratio 1:1 followed by centrifugation. Cooled ethyl alcohol is added again to the remained solution in the ratio 2: 1. After centrifugation precipitate is obtained that is a human alpha-fetoprotein with purity 90%, not less. Polysaccharide is added to the obtained alpha-fetoprotein followed by package and lyophilic drying. EFFECT: decreased cost, high purity of end product, simplified method. 2 cl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF ALPHA-FETOPROTEIN PREPARATION PREPARING | 2000 |
|
RU2169578C1 |
METHOD OF ALPHA-FETOPROTEIN PREPARING | 1995 |
|
RU2100031C1 |
METHOD FOR PREPARING PREPARATION DRY ALPHA-FETOPROTEIN | 2005 |
|
RU2283131C1 |
METHOD OF PREPARING AN ALPHA-FETOPROTEIN PREPARATION | 1996 |
|
RU2121350C1 |
METHOD FOR PREPARING ALPHA-FETOPROTEIN PREPARATION TABLET | 2005 |
|
RU2319479C2 |
METHOD FOR PRODUCTION OF ALPHA-FETOPROTEIN | 2006 |
|
RU2308286C1 |
MEDICATION COMPOSITION AND METHOD OF ITS OBTAINING FOR TREATMENT OF CHRONIC VIRAL HEPATITIS B OR C AND AIDS | 2010 |
|
RU2440133C2 |
METHOD OF INDUSTRIAL OBTAINING PREPARATION OF ALPHA-FETOPROTEIN | 2010 |
|
RU2448727C2 |
METHOD OF DNA TABLET MAKING | 2000 |
|
RU2170084C1 |
METHOD OF ALPHA-FETOPROTEIN PREPARATION PREPARING | 1998 |
|
RU2123009C1 |
Authors
Dates
2001-07-20—Published
2000-02-23—Filed